News and Announcements
Cre8tek announces Technology Partnership with Industrie&Co
- Published May 09, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Cre8tek Limited (ASX: CR8), owner of high tech, Artificial Intelligence company and Cognitive Virtual Assistant platform provider, Flamingo Customer Experience Inc. (Flamingo), is pleased to announce that Flamingo have partnered with information technology solutions firm, Industrie&Co.
KEY TAKEAWAYS:
- TechnologyPartnership with Industrie&Co;
- Initial focus will be on Industrie&Co conducting Flamingo platform integrations;
- ASX listed fintech, DirectMoney to be first client for integration partnership, to support their online personal loan product;
- Industrie&Copartnership assists Flamingo with scalability of platform, business and revenue streams;
The intention of both parties is to enter into a longer term strategic and commercial partnership, encompassing both future integrations but also lead generation opportunities through Industrie&Co’s substantial customer network.
CEO of Industrie&Co, Con Zeritis, stated, “We are thrilled to partner with Flamingo and to be able to support them in their exciting plans for growth across APAC. We believe that conversational commerce is a critically important paradigm that all organisations need to embrace. Having supported Catriona and the team from their early stage, we have a strong appreciation of their vision and capability and see the platform as a unique enabler that many organisations can leverage.”
CEO of Cre8tek, Dr Catriona Wallace, stated, “This partnership with Industrie&Co provides Flamingo with the capability to hasten integration and deployment times as well as generating other potential revenue opportunities. This partnership is one of several we are undertaking in order to scale the Flamingo business and speed the path to revenue”.
This is one of several discussions that Flamingo has recently been engaged in with potential re-seller and integration partners across its priority markets to accelerate the scale of the business, and open additional revenue streams.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
